Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency

Machine translation Machine translation
Catégorie Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2006
Liens Database of Abstracts of Reviews of Effects (DARE)

Cet article inclut 1 Systematic review Systematic reviews (1 reference)

Loading references information

RÉSUMÉ CRD:

Cette revue bien menée a évalué le niveau d'héparine anti-Xa et événements hémorragiques chez les patients atteints d'insuffisance rénale sévère qui recevaient l'héparine de bas poids moléculaire. Elle a conclu que des doses standard thérapeutiques de l'énoxaparine a conduit à des niveaux plus élevés d'anti-Xa d'héparine et a augmenté le risque de saignement majeur. Ces conclusions sont limitées par la nature observationnelle des études incluses.
Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright © 2012 University of York
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: 5f4fd5ca0d3c0203bbfa2cdc101f32a1672aa501
First added on: Jun 07, 2012
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use